“…Additionally, for the overall population, there were 1990 patients (12.17%) receiving preoperative radiotherapy in the primary closure group and 425 patients (27.12%) in the myocutaneous flap closure group, with a significant difference between the two groups. Among these included studies, one performed the propensity matching analysis, four matched BMI, 12 matched comorbidities and six matched preoperative radiotherapy [8,[26][27][28][29][30][31][32][33][34][36][37][38][39][40]. Nine studies on stage of cancer had the following distribution: low tumour stage (I-II) (252 cases in primary closure, 1.54%; 101 cases in myocutaneous flap closure, 6.45%) and advanced tumour stage (III-IV) (312 cases in primary closure, 1.91%; 124 cases in myocutaneous flap closure, 7.91%) [8,26,28,30,[32][33][34]38,39].…”